Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 17, Status: Authorised
On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services
Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 27, Status: Authorised
European Medicines Agency Write PMS API implementation Guide
Guidelines Consistency Group
Applications for new human medicines under evaluation: November 2025
Minutes - PDCO minutes of the 9-12 September 2025 meeting
Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 13, Status: Authorised
Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP